Isolation of HIV-1-reactive antibodies using cell surface-expressed gp160δcBaL

Journal of Immunological Methods

Volumn 397, Issue 1-2, 2013, Pages 47-54

  Gaebler, Christian ^a,b   Gruell, Henning ^a,c   Velinzon, Klara ^a   Scheid, Johannes F ^a,d   Nussenzweig, Michel C ^a   Klein, Florian ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c INST OF REPRO MED OF THE UNIV   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

HIV 1; HIV 1 neutralizing antibodies; Single B cell sort; Surface expressed envelope trimer

Indexed keywords

ENVELOPE PROTEIN; GLYCOPROTEIN GP 160; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIBODY ISOLATION; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; VIRUS ENVELOPE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84885959138     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.09.003     Document Type: Article

References (49)

1. Battye F.L., Light A., Tarlinton D.M. Single cell sorting and cloning. J. Immunol. Methods 2000, 243:25.
2. Binley J.M., Sanders R.W., Clas B., Schuelke N., Master A., Guo Y., Kajumo F., Anselma D.J., Maddon P.J., Olson W.C., Moore J.P. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J. Virol. 2000, 74:627.
3. Bonsignori M., Hwang K.K., Chen X., Tsao C.Y., Morris L., Gray E., Marshall D.J., Crump J.A., Kapiga S.H., Sam N.E., Sinangil F., Pancera M., Yongping Y., Zhang B., Zhu J., Kwong P.D., O'Dell S., Mascola J.R., Wu L., Nabel G.J., Phogat S., Seaman M.S., Whitesides J.F., Moody M.A., Kelsoe G., Yang X., Sodroski J., Shaw G.M., Montefiori D.C., Kepler T.B., Tomaras G.D., Alam S.M., Liao H.X., Haynes B.F. Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J. Virol. 2011, 85:9998.
4. Bothmer A., Rommel P.C., Gazumyan A., Polato F., Reczek C.R., Muellenbeck M.F., Schaetzlein S., Edelmann W., Chen P.L., Brosh R.M., Casellas R., Ludwig T., Baer R., Nussenzweig A., Nussenzweig M.C., Robbiani D.F. Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switching. J. Exp. Med. 2013, 210:115.
5. Burton D.R., Ahmed R., Barouch D.H., Butera S.T., Crotty S., Godzik A., Kaufmann D.E., McElrath M.J., Nussenzweig M.C., Pulendran B., Scanlan C.N., Schief W.R., Silvestri G., Streeck H., Walker B.D., Walker L.M., Ward A.B., Wilson I.A., Wyatt R. A blueprint for HIV vaccine discovery. Cell Host Microbe 2012, 12:396.
6. Callewaert D., Radcliff G., Waite R., Lefevre J., Poulik M. Characterization of effector-target conjugates for cloned human natural-killer and human lymphokine activated killer-cells by flow-cytometry. Cytometry 1991, 12:666.
7. Cavarec L., Quillet-Mary A., Fradelizi D., Conjeaud H. An improved double fluorescence flow cytometry method for the quantification of killer cell/target cell conjugate formation. J. Immunol. Methods 1990, 130:251.
8. Crooks E.T., Tong T., Osawa K., Binley J.M. Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected. J. Virol. 2011, 85:5825.
9. Davenport T.M., Friend D., Ellingson K., Xu H., Caldwell Z., Sellhorn G., Kraft Z., Strong R.K., Stamatatos L. Binding Interactions between soluble HIV envelope glycoproteins and quaternary-structure-specific monoclonal antibodies PG9 and PG16. J. Virol. 2011, 85:7095.
10. Diskin R., Scheid J.F., Marcovecchio P.M., West A.P., Klein F., Gao H., Gnanapragasam P.N.P., Abadir A., Seaman M.S., Nussenzweig M.C., Bjorkman P.J. Increasing the potency and breadth of an HIV antibody by using structure-based rational design. Science (New York, NY) 2011, 334:1289.
11. Fouts T.R., Binley J.M., Trkola A., Robinson J.E., Moore J.P. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex. J. Virol. 1997, 71:2779.
12. Georgiev I.S., Doria-Rose N.A., Zhou T., Kwon Y.D., Staupe R.P., Moquin S., Chuang G.Y., Louder M.K., Schmidt S.D., Altae-Tran H.R., Bailer R.T., McKee K., Nason M., O'Dell S., Ofek G., Pancera M., Srivatsan S., Shapiro L., Connors M., Migueles S.A., Morris L., Nishimura Y., Martin M.A., Mascola J.R., Kwong P.D. Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization. Science 2013, 340:751.
13. Gorny M.K., Stamatatos L., Volsky B., Revesz K., Williams C., Wang X.-H., Cohen S., Staudinger R., Zolla-Pazner S. Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles. J. Virol. 2005, 79:5232.
14. Harris A., Borgnia M.J., Shi D., Bartesaghi A., He H., Pejchal R., Kang Y.K., Depetris R., Marozsan A.J., Sanders R.W., Klasse P.J., Milne J.L.S., Wilson I.A., Olson W.C., Moore J.P., Subramaniam S. Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:11440.
15. Hauss P., Selz F., Fischer A. Comparative analysis of CD4-mediated down-regulation of T cell adhesion to B cells by flow cytometry and fluorescence microscopy. Cytometry 1996, 23:39.
16. Hessell A.J., Poignard P., Hunter M., Hangartner L., Tehrani D.M., Bleeker W.K., Parren P.W., Marx P.A., Burton D.R. Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques. Nat. Med. 2009, 15:951.
17. Hicar M.D., Chen X., Briney B., Hammonds J., Wang J.-J., Kalams S., Spearman P.W., Crowe J.E. Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV. J. Acquir. Immune Defic. Syndr. 2010, 54:223.
18. Huang J., Ofek G., Laub L., Louder M.K., Doria-Rose N.A., Longo N.S., Imamichi H., Bailer R.T., Chakrabarti B., Sharma S.K., Alam S.M., Wang T., Yang Y., Zhang B., Migueles S.A., Wyatt R., Haynes B.F., Kwong P.D., Mascola J.R., Connors M. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature 2012, 491:406.
19. Hubbard B., Glacken M., Rodgers J., Rich R. The role of physical forces on cytotoxic T cell-target cell conjugate stability. J. Immunol. 1990, 144:4129.
20. Julien J.P., Lee J.H., Cupo A., Murin C.D., Derking R., Hoffenberg S., Caulfield M.J., King C.R., Marozsan A.J., Klasse P.J., Sanders R.W., Moore J.P., Wilson I.A., Ward A.B. Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:4351.
21. Klein F., Gaebler C., Mouquet H., Sather D.N., Lehmann C., Scheid J.F., Kraft Z., Liu Y., Pietzsch J., Hurley A., Poignard P., Feizi T., Morris L., Walker B.D., Fatkenheuer G., Seaman M.S., Stamatatos L., Nussenzweig M.C. Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein. J. Exp. Med. 2012, 209:1469.
22. Klein F., Halper-Stromberg A., Horwitz J.A., Gruell H., Scheid J.F., Bournazos S., Mouquet H., Spatz L.A., Diskin R., Abadir A., Zang T., Dorner M., Billerbeck E., Labitt R.N., Gaebler C., Marcovecchio P.M., Incesu R.B., Eisenreich T.R., Bieniasz P.D., Seaman M.S., Bjorkman P.J., Ravetch J.V., Ploss A., Nussenzweig M.C. HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature 2012, 492:118.
23. Liao H.X., Lynch R., Zhou T., Gao F., Alam S.M., Boyd S.D., Fire A.Z., Roskin K.M., Schramm C.A., Zhang Z., Zhu J., Shapiro L., Program N.C.S., Mullikin J.C., Gnanakaran S., Hraber P., Wiehe K., Kelsoe G., Yang G., Xia S.M., Montefiori D.C., Parks R., Lloyd K.E., Scearce R.M., Soderberg K.A., Cohen M., Kamanga G., Louder M.K., Tran L.M., Chen Y., Cai F., Chen S., Moquin S., Du X., Joyce M.G., Srivatsan S., Zhang B., Zheng A., Shaw G.M., Hahn B.H., Kepler T.B., Korber B.T., Kwong P.D., Mascola J.R., Haynes B.F. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 2013, 496:469.
24. Mascola J.R., Stiegler G., VanCott T.C., Katinger H., Carpenter C.B., Hanson C.E., Beary H., Hayes D., Frankel S.S., Birx D.L., Lewis M.G. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 2000, 6:207.
25. McBride K.M., Gazumyan A., Woo E.M., Barreto V.M., Robbiani D.F., Chait B.T., Nussenzweig M.C. Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:8798.
26. McCoy L.E., Weiss R.A. Neutralizing antibodies to HIV-1 induced by immunization. J. Exp. Med. 2013, 210:209.
27. Moore P.L., Crooks E.T., Porter L., Zhu P., Cayanan C.S., Grise H., Corcoran P., Zwick M.B., Franti M., Morris L., Roux K.H., Burton D.R., Binley J.M. Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. J. Virol. 2006, 80:2515.
28. Moore P.L., Gray E.S., Sheward D., Madiga M., Ranchobe N., Lai Z., Honnen W.J., Nonyane M., Tumba N., Hermanus T., Sibeko S., Mlisana K., Abdool Karim S.S., Williamson C., Pinter A., Morris L., Study C. Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop. J. Virol. 2011, 85:3128.
29. Morris L., Chen X., Alam M., Tomaras G., Zhang R., Marshall D.J., Chen B., Parks R., Foulger A., Jaeger F., Donathan M., Bilska M., Gray E.S., Abdool Karim S.S., Kepler T.B., Whitesides J., Montefiori D., Moody M.A., Liao H.-X., Haynes B.F. Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting. PLoS One 2011, 6:e23532.
30. Mouquet H., Klein F., Scheid J.F., Warncke M., Pietzsch J., Oliveira T.Y., Velinzon K., Seaman M.S., Nussenzweig M.C. Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses. PLoS One 2011, 6:e24078.
31. Mouquet H., Scharf L., Euler Z., Liu Y., Eden C., Scheid J.F., Halper-Stromberg A., Gnanapragasam P.N., Spencer D.I., Seaman M.S., Schuitemaker H., Feizi T., Nussenzweig M.C., Bjorkman P.J. Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E3268.
32. Paige C.J., Kincade P.W., Ralph P. Murine B cell leukemia line with inducible surface immunoglobulin expression. J. Immunol. 1978, 121:641.
33. Pancera M., Wyatt R. Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage. Virology 2005, 332:145.
34. Pejchal R., Doores K.J., Walker L.M., Khayat R., Huang P.S., Wang S.K., Stanfield R.L., Julien J.P., Ramos A., Crispin M., Depetris R., Katpally U., Marozsan A., Cupo A., Maloveste S., Liu Y., McBride R., Ito Y., Sanders R.W., Ogohara C., Paulson J.C., Feizi T., Scanlan C.N., Wong C.H., Moore J.P., Olson W.C., Ward A.B., Poignard P., Schief W.R., Burton D.R., Wilson I.A. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science (New York, NY) 2011, 334:1097.
35. Pietzsch J., Scheid J.F., Mouquet H., Klein F., Seaman M.S., Jankovic M., Corti D., Lanzavecchia A., Nussenzweig M.C. Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness. J. Exp. Med. 2010, 207:1995.
36. Poignard P., Moulard M., Golez E., Vivona V., Franti M., Venturini S., Wang M., Parren P.W.H.I., Burton D.R. Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies. J. Virol. 2003, 77:353.
37. Robinson J.E., Franco K., Elliott D.H., Maher M.J., Reyna A., Montefiori D.C., Zolla-Pazner S., Gorny M.K., Kraft Z., Stamatatos L. Quaternary epitope specificities of anti-HIV-1 neutralizing antibodies generated in rhesus macaques infected by the simian/human immunodeficiency virus SHIVSF162P4. J. Virol. 2010, 84:3443.
38. Scheid J.F., Mouquet H., Feldhahn N., Seaman M.S., Velinzon K., Pietzsch J., Ott R.G., Anthony R.M., Zebroski H., Hurley A., Phogat A., Chakrabarti B., Li Y., Connors M., Pereyra F., Walker B.D., Wardemann H., Ho D., Wyatt R.T., Mascola J.R., Ravetch J.V., Nussenzweig M.C. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 2009, 458:636.
39. Scheid J.F., Mouquet H., Feldhahn N., Walker B.D., Pereyra F., Cutrell E., Seaman M.S., Mascola J.R., Wyatt R.T., Wardemann H., Nussenzweig M.C. A method for identification of HIV gp140 binding memory B cells in human blood. J. Immunol. Methods 2009, 343:65.
40. Scheid J.F., Mouquet H., Ueberheide B., Diskin R., Klein F., Olivera T.Y., Pietzsch J., Fenyo D., Abadir A., Velinzon K., Hurley A., Myung S., Boulad F., Poignard P., Burton D., Pereyra F., Ho D.D., Walker B.D., Seaman M.S., Bjorkman P.J., Chait B.T., Nussenzweig M.C. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 2011, 333:1633.
41. Segal D.M., Stephany D.A. The measurement of specific cell: cell interactions by dual-parameter flow cytometry. Cytometry 1984, 5:169.
42. Szymczak A.L., Workman C.J., Wang Y., Vignali K.M., Dilioglou S., Vanin E.F., Vignali D.A. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat. Biotechnol. 2004, 22:589.
43. Tiller T., Meffre E., Yurasov S., Tsuiji M., Nussenzweig M.C., Wardemann H. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 2008, 329:112.
44. Walker L.M., Phogat S.K., Chan-Hui P.Y., Wagner D., Phung P., Goss J.L., Wrin T., Simek M.D., Fling S., Mitcham J.L., Lehrman J.K., Priddy F.H., Olsen O.A., Frey S.M., Hammond P.W., Kaminsky S., Zamb T., Moyle M., Koff W.C., Poignard P., Burton D.R. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 2009, 326:285.
45. Walker L.M., Simek M.D., Priddy F., Gach J.S., Wagner D., Zwick M.B., Phogat S.K., Poignard P., Burton D.R. A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals. PLoS Pathog. 2010, 6:e1001028.
46. Walker L.M., Huber M., Doores K.J., Falkowska E., Pejchal R., Julien J.-P., Wang S.-K., Ramos A., Chan-Hui P.-Y., Moyle M., Mitcham J.L., Hammond P.W., Olsen O.A., Phung P., Fling S., Wong C.-H., Phogat S., Wrin T., Simek M.D., Investigators P.G.P., Koff W.C., Wilson I.A., Burton D.R., Poignard P. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 2011, 1-6.
47. Wardemann H., Yurasov S., Schaefer A., Young J.W., Meffre E., Nussenzweig M.C. Predominant autoantibody production by early human B cell precursors. Science (New York, NY) 2003, 301:1374.
48. West A.P., Scharf L., Horwitz J., Klein F., Nussenzweig M.C., Bjorkman P.J. Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:10598.
49. Wu X., Yang Z.Y., Li Y., Hogerkorp C.M., Schief W.R., Seaman M.S., Zhou T., Schmidt S.D., Wu L., Xu L., Longo N.S., McKee K., O'Dell S., Louder M.K., Wycuff D.L., Feng Y., Nason M., Doria-Rose N., Connors M., Kwong P.D., Roederer M., Wyatt R.T., Nabel G.J., Mascola J.R. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 2010, 329:856.